Overview
Description
Lonza Group AG is a leading global provider in the life sciences industry, specializing in the development and manufacture of chemical and biological ingredients. Headquartered in Basel, Switzerland, Lonza plays a critical role in the pharmaceutical and biotechnology sectors by supplying essential products for drug production, gene and cell therapy manufacturing, and active pharmaceutical ingredients. The company's extensive expertise extends to the production of microbials and nutrition components, serving industries ranging from healthcare to personal care and nutrition. With its robust capabilities, Lonza supports innovative therapies that enhance human health and well-being. In the financial market, Lonza is recognized for its pivotal contributions to the pharmaceutical supply chain and its commitment to sustainable and technological advancements in life sciences. Its global operations include state-of-the-art facilities and research centers that collaborate with clients in bringing cutting-edge solutions to market, reinforcing its position as a vital player in the healthcare industry.
About
CEO
Mr. Albert M. Baehny
Employees
17995
Address
Muenchensteinerstrasse 38
Basel, 4002
Basel, 4002
Phone
41 61 316 81 11
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
MIC code
PINX